Transduced B cells: B is for 'beneficial'!

European Journal of Immunology

Volumn 41, Issue 6, 2011, Pages 1528-1530

  Scott, David W ^a  

^a Uniformed Services University of the Health Sciences   (United States)

Author keywords

B cells; Gene therapy; Lentivirus; Tolerance

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD69 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 17; LENTIVIRUS VECTOR; TUMOR NECROSIS FACTOR;

B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CELL BASED GENE THERAPY; CELLULAR IMMUNITY; CLINICAL PROTOCOL; CYTOKINE PRODUCTION; ENZYME INDUCTION; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; LENTIVIRINAE; NOTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CLONAL ANERGY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; IMMUNOSUPPRESSION; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-10; MULTIPLE SCLEROSIS; MYELIN-ASSOCIATED GLYCOPROTEIN; T-LYMPHOCYTES, REGULATORY; TRANSGENES;

EID: 79957579027     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201141649     Document Type: Note

References (22)

1. Calderon-Gomez, E., Lampropoulou, V., Shen, P., Neves, P., Roch, T., Stervbo, U., Rutz, S. et al., Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitis. Eur. J. Immunol. 2011. 41: 1696-1708.
2. Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., Anderton, S. M., B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 2002. 3: 944-950.
3. Lei, T. C., Su, Y., Scott, D. W., Tolerance induction via a B-cell delivered gene therapy-based protocol: optimization and role of the Ig scaffold. Cell Immunol. 2005. 235: 12-20.
4. Fuchs, E. J., Matzinger, P., B cells turn off virgin but not memory T cells. Science 1992. 258: 1156-1159.
5. Eynon, E. E., Parker, D. C., Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 1992. 175: 131-138.
6. Serreze, D. V., Chapman, H. D., Varnum, D. S., Hanson, M. S., Reifsnyder, P. C., Richard, S. D., Fleming, S. A., Leiter, E. H., Shultz, L. D., B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD. Ig mu null mice. J. Exp. Med. 1996. 184: 2049-2053.
7. Gilbert, K. M., Weigle, W. O., Tolerogenicity of resting and activated B cells. J. Exp. Med. 1994. 179: 249-258.
8. Zambidis, E. T., Barth, R. K., Scott, D. W., Both resting and activated B lymphocytes expressing engineered peptide-Ig molecules serve as highly efficient tolerogenic vehicles in immunocompetent adult recipients. J. Immunol. 1997. 158: 2174-2182.
9. Chen, C. C., Rivera, A., Dougherty, J. P., Ron, Y., Complete protection from relapsing experimental autoimmune encephalomyelitis induced by syngeneic B cells expressing the autoantigen. Blood 2004. 103: 4616-4618.
10. Agarwal, R. K., Kang, Y., Zambidis, E., Scott, D. W., Chan, C. C., Caspi, R. R., Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. J. Clin. Invest. 2000. 106: 245-252.
11. Xu, B., Scott, D. W., A novel retroviral gene therapy approach to inhibit specific antibody production and suppress experimental autoimmune encephalomyelitis induced by MOG and MBP. Clin. Immunol. 2004. 111: 47-52.
12. Melo, M. E., Qian, J., El-Amine, M., Agarwal, R. K., Soukhareva, N., Kang, Y., Scott, D. W., Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases. J. Immunol. 2002. 168: 4788-4795.
13. Soukhareva, N., Jiang, Y., Scott, D. W., Treatment of diabetes in NOD mice by gene transfer of Ig-fusion proteins into B cells: Role of T regulatory cells. Cell Immunol. 2006. 240: 41-46.
14. Lei, T. C., Scott, D. W., Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins. Blood 2005. 105: 4865-4870.
15. + regulatory T cells and TGF-beta? Gene Ther. 2004. 11: 1487-1496.
16. El-Amine, M., Melo, M., Kang, Y., Nguyen, H., Qian, J., Scott, D. W., Mechanisms of tolerance induction by a gene-transferred peptide-IgG fusion protein expressed in B lineage cells. J. Immunol. 2000. 165: 5631-5636.
17. Ahangarani, R. R., Janssens, W., VanderElst, L., Carlier, V., VandenDriessche, T., Chuah, M., Weynand et al., In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term IL-10-dependent antigen-specific unresponsiveness. J. Immunol. 2009. 183: 8232-8243.
18. Ahangarani, R. R., Janssens, W., Carlier, V., Vanderelst, L., Vandendriessche, T., Chuah, M., Jacquemin, M., Saint-Remy, J. M., Retroviral vectors induce epigenetic chromatin modifications and IL-10 Production in transduced B cells via activation of toll-like receptor 2. Mol Ther. 2011. 19: 711-722.
19. Litzinger, M. T., Su, Y., Lei, T. C., Soukhareva, N., Scott, D. W., Mechanisms of gene therapy for tolerance: B7 signaling is required for peptide-IgG gene-transferred tolerance induction. J. Immunol. 2005. 175: 780-787.
20. Frecha, C., Costa, C., Levy, C., Negre, D., Russell, S. J., Maisner, A., Salles, G., Peng, K. W., Cosset, F. L., Verhoeyen, E., Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors. Blood 2009. 114: 3173-3180.
21. Vanderlugt, C. L., Miller, S. D., Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2002. 2: 85-95.
22. Annoni, A., Brown, B. D., Cantore, A., Sergi, L. S., Naldini, L., Roncarolo, M. G., In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance. Blood 2009. 114: 5152-5161.